Treatment of neuropathic pain with repeated low-dose MDMA: a case report
A 64-year-old male patient who suffered from traumatic life experiences and neuropathic pain after oncological chemotherapy was treated with medium to high doses of lysergic acid diethylamide (LSD) and high doses and microdoses of methylenedioxymethamphetamine (MDMA). At the beginning of treatment,...
Saved in:
Main Authors: | Peter Gasser, Matthias E. Liechti, Friederike Holze |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1513022/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting
by: Dimitri Perivoliotis, et al.
Published: (2025-01-01) -
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01) -
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy
by: Joseph A. Zamaria, et al.
Published: (2025-02-01) -
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
by: Alice Melani, et al.
Published: (2025-01-01) -
PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY
by: JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
Published: (2024-11-01)